SMS Pharmaceuticals Ltd.
SMS Pharmaceuticals Ltd.
Quarterly financials.
(INR) Sept 2023 Y/Y
Revenue 166.64Cr 4.52%
Net income 11.73Cr 683.8%
Net profit margin 7.04% 658.73%
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.